Form 4: Alignment Healthcare CFO Robert Freeman Sells Shares Under 10b5-1 Plan

Robert Freeman, CFO of Alignment Healthcare, executed sales of common stock on October 29 and October 31, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Robert Freeman, the Chief Financial Officer of Alignment Healthcare, sold shares of common stock on October 29 and October 31, 2024.
• The sales were executed under a pre-arranged trading plan pursuant to Rule 10b5-1(c), which was adopted on March 15, 2024.
• On October 29, 2024, 4,483 shares were sold at a weighted-average price of $12.0134 per share, with individual prices ranging from $12.00 to $12.05.
• Following this transaction, Mr. Freeman directly owns 865,407 shares and indirectly owns 159,626 shares through FCO Holdings LLC.
• On October 31, 2024, 36,197 shares were sold at a weighted-average price of $12.0447 per share, with individual prices ranging from $12.00 to $12.24.
• Following this transaction, Mr. Freeman directly owns 865,407 shares and indirectly owns 123,429 shares through FCO Holdings LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Insider selling can sometimes be viewed negatively by the market, but the use of a pre-arranged 10b5-1 trading plan often mitigates concerns as it demonstrates that the sales were planned in advance and not based on inside information.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan should reassure investors that the sales were pre-planned.

Key Dates